Laura Prendergast
Analyst
Analyst — Stifel
Earnings-call appearances
-
Revolution Medicines, Inc. Q1 FY2026 Earnings Call2026-05-06
Revolution Medicines, Inc. (RVMD)
-
Revolution Medicines, Inc. Q3 FY2025 Earnings Call2025-11-05
Revolution Medicines, Inc. (RVMD)
-
Allogene Therapeutics, Inc. Q4 FY2024 Earnings Call2025-03-13
Allogene Therapeutics, Inc. (ALLO)
-
Revolution Medicines, Inc. Q4 FY2024 Earnings Call2025-02-26
Revolution Medicines, Inc. (RVMD)
-
Allogene Therapeutics, Inc. Q3 FY2024 Earnings Call2024-12-02
Allogene Therapeutics, Inc. (ALLO)
-
Revolution Medicines, Inc. Q3 FY2024 Earnings Call2024-11-06
Revolution Medicines, Inc. (RVMD)
-
Revolution Medicines, Inc. Q2 FY2024 Earnings Call2024-08-07
Revolution Medicines, Inc. (RVMD)
-
Allogene Therapeutics, Inc. Q1 FY2024 Earnings Call2024-05-13
Allogene Therapeutics, Inc. (ALLO)
-
Revolution Medicines, Inc. Q1 FY2024 Earnings Call2024-05-08
Revolution Medicines, Inc. (RVMD)
-
Allogene Therapeutics, Inc. Q4 FY2023 Earnings Call2024-03-14
Allogene Therapeutics, Inc. (ALLO)
-
Revolution Medicines, Inc. Q4 FY2023 Earnings Call2024-02-26
Revolution Medicines, Inc. (RVMD)